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Abstract. Following abrupt phase shifts (real or simulated time zone 
changes, night shift work) there is desynchronisation between the 
internal circadian rhythms (including melatonin) and the external 
environment with consequent disturbances in sleep, mood and 
performance. In humans the pineal hormone melatonin has 
phase-shifting and resynchronising properties with regard to a number 
of circadian rhythms. Suitably timed melatonin adrninstration hastened 
adaptation to phase shift and significantly improved self-rated jet lag in 
large numbers of time zone travellers. Preliminary results in night shift 
workers showed improved daytime sleep and night-time alertness. In 
simulated experiments, appropriately timed melatonin improved 
subjective sleep, alertness and performance and facilitated the 
readaptation of the melatonin rhythm following a rapid 9 h advance 
phase shift. Melatonin has also been assessed in circadian rhythm 
disorders with disturbed sleep (blindness and delayed sleep phase 
insomnia). Compared with placebo, melatonin significantly improved 
sleep and synchronised the sleep wake cycle in some blind subjects. 
Melatonin treatment significantly advanced the sleep onset time in 
delayed sleep phase insomnia. Taken together these findings suggest 
that melatonin is of benefit in facilitating adaptation to forced phase 
shifts and in conditions of circadian rhythm disturbance. 
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INTRODUCTION 
In all species studied to date, including man, syn- 
thesis of the pineal gland hormone melatonin has a 
day-night variation with peak levels occurring in 
the dark phase. The melatonin rhythm is an en- 
dogenous circadian rhythm which is driven by the 
circadian pacemaker located in the hypothalamic 
suprachiasmatic nuclei (SCN). In photoperiodic 
species the rhythmic production of melatonin con- 
veys information about the prevailing light/dark 
cycle for the timing of seasonal functions. 
Animal studies have demonstrated that exogen- 
ous melatonin has resynchronising properties. Me- 
latonin injections synchronised the free running 
rest-activity cycles in rats kept in constant darkness 
(Redman et al. 1983). In addition, melatonin treat- 
ment altered the rate and direction of re-entrainment 
of rat locomotor activity following phase shifts 
(Armstrong and Redman 1985). More recently evi- 
dence has accumulated which suggests that mela- 
tonin acts via the SCN to affect these circadian 
rhythms. Melatonin receptors have been identified 
in the SCN of numerous species (review Morgan et 
al. 1994), including man (Reppert et al. 1988). The 
ability of appropriately timed melatonin to phase 
advance free running locomotor activity in rats 
(Redman et al. 1983) is blocked by SCN ablation 
(Cassone et al. 1986). In vitro SCN electrical activ- 
ity is phase advanced by melatonin applied around 
the day-night transition (McArthur et al. 1991). 
Whether melatonin has phase-shifting and re- 
synchronising properties in humans, and if so, 
whether this will be of therapeutic benefit in facili- 
tating adaptation to forced phase shifts and in con- 
ditions of circadian rhythm disturbances has been 
investigated in our laboratory. This review sum- 
marises these studies. 
EFFECT OF EXOGENOUS 
MELATONIN 
Early work showed that timed administration of 
melatonin to healthy volunteers (2 mg daily at 17.00 
h for 4 weeks) phase advanced its own endogenous 
rhythm and increased self-rated evening fatigue 
after 4 days of treatment (Arendt et al. 1984, 1985, 
Wright et al. 1986). Compared with placebo, no 
changes in mood, cortisol, GH, LH, testosterone 
and T4 levels were observed, although a small ad- 
vance of the morning decline of prolactin was seen. 
Recently melatonin (single 5 mg dose at 17.00 h) 
has been shown to induce a significant suppression 
of core body temperature and self-rated alertness 
followed by a phase advance of the onset of en- 
dogenous melatonin the following evening (Deacon 
et a1 1994). Further work has found these effects to 
be dose-dependent (Deacon and Arendt 1995a). 
MELATONIN AND ADAPTATION 
TO PHASE SHIFT 
Following abrupt phase shifts (real or simulated 
time zone changes, night shift work) there is a mis- 
match between the internal circadian rhythms (in- 
cluding melatonin) and the external environment 
with consequent disturbances in sleep, mood and 
performance. In the first placebo controlled jet lag 
study, melatonin (5 mg) significantly improved 
self-rated jet lag, daytime alertness, sleep latency 
and quality, and hastened the rate of resynchronisa- 
tion of endogenous melatonin and cortisol rhythms 
(Arendt et al. 1986, 1987). A subsequent double- 
blind cross-over study (Skene et al. 1989) demon- 
strated that melatonin, appropriately timed to 
induce phase advances or delays, was highly effec- 
tive in improving jet lag, although a small minority 
( 10%) of subjects felt worse. Results from allplace- 
bo-controlled and uncontrolled studies (melatonin 
n=474, placebo n=112) indicate that, suitably 
timed, melatonin reduces self-rated jet lag by 50% 
(P ~0 .001)  in the majority of air travellers (irrespec- 
tive of age, sex and direction of travel). 
The use of melatonin in field studies of shift wor- 
kers is still in its infancy. A preliminary study of 
night shift workers showed that melatonin taken at 
the desired bedtime following a 8 h night shift im- 
proved self-rated sleep quality and sleep duration 
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with increased alertness during the work shift 
(Folkard et al. 1993). 
Field studies are expensive and difficult to con- 
trol with respect to the physical and social environ- 
ment. Thus in order to address some questions about 
melatonin's action, simulated phase shift experi- 
ments have been set up in the laboratory. Moderate- 
ly bright light (1,200 lux) at night followed by 
imposed darkness is used to phase shift subjects in 
a controlled environment. This protocol induces a 
gradual 9 h delay phase shift in the circadian system 
following which the subjects are released back into 
the baseline environment, simulating a rapid time 
zone change or a change to a new shift work sche- 
dule (Deacon and Arendt 1995b). In such simulated 
experiments, appropriately timed melatonin (5 mg) 
improved subjective sleep, alertness and perfor- 
mance and facilitated the readaptation of the mela- 
tonin rhythm following the rapid 9 h advance phase 
shift (Deacon and Arendt 199%). 
MELATONIN AND CIRCADIAN 
RHYTHM DISORDERS 
Melatonin has also been assessed in conditions 
of biological rhythm disturbances with disturbed 
sleep (blind subjects and patients with delayed sleep 
phase insomnia). Compared with placebo, mela- 
tonin significantly improved sleep and syn- 
chronised the sleep wake cycle in some blind 
subjects (Aldhous and Arendt 199 1). Intensive 
study of one free running blind man showed that 
melatonin synchronised the sleeplwake cycle (pri- 
marily by stabilising sleep onset) and reduced day- 
time sleepiness without synchronising the 
endogenous rhythms of melatonin, cortisol and core 
body temperature (Arendt et al. 1988, Folkard et al. 
1990). Detailed investigation of the circadian 
rhythm abnormalities in blind subjects prior to me- 
latonin administration is currently underway so that 
the timing of melatonin administration can be opti- 
mised for each individual. 
An effect on sleep onset was also observed in pa- 
tients with delayed sleep phase insomnia, melatonin 
administration (5 mg) at bedtime advancing sleep 
onset in all subjects (Dahlitz et al. 1991). 
CONCLUSIONS 
These findings suggest that melatonin is of 
benefit in facilitating adaptation to forced phase 
shifts and in conditions of circadian rhythm disturb- 
ance. Optimisation of dose and timing of adminis- 
tration require further investigation. Application of 
the human phase response curve to melatonin 
(Lewy et al. 1992, Zaidan et al. 1994), and knowl- 
edge of an individual's circadian status prior to me- 
latonin administration will assist in the design of 
effective treatment regimens. 
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